Application

14826515 · ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15

Filed 2015-08-14 · Granted · Patent 9815899 (2017-11-14) The official file ↗The patent and its PDF ↗ · Art unit 1646 · Examiner Elizabeth Kemmerer Typical · CPC A61K 31/593 · Daiichi Sankyo Company, Limited · FOLEY & LARDNER LLP

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

11.3 mo

to disposition 27.0 mo

Statutes raised

102 112 DP

3 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.